Serum Institute of India (SII) and Bharat Biotech have pledged to ensure global access to their vaccines against the coronavirus disease (Covid-19). “We are fully aware of the importance of vaccines for people and countries alike. We hereby communicate our joint pledge to provide global access for our Covid-19 vaccines,” SII and Bharat Biotech said in a joint statement, according to ANI.
The statement said that SII’s Adar Poonawalla and Bharat Biotech’s Krishna Ella are focusing on manufacturing, supply and distribution of the vaccines. The joint statement said that both companies are fully engaged in this activity and consider it as their duty to provide the vaccines to the citizens and people worldwide.
Source: Read Full Article